ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 62996-74-1
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Natural Products
  6. Staurosporine

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttp://www.medchemexpress.com/
Wechat
Product NameStaurosporine
SynonymsCS-2206
AM-2282
CGP 39360
CCRIS 3272
Staurosporin
Staurosporine
Antibiotic 230

Synonyms

CS-2206
AM-2282
CGP 39360
CCRIS 3272
Staurosporin
Staurosporine
Antibiotic 230
(+)-Staurosporine
Antibiotic AM 2282
Staurosporineinsolution
Staurosporine, Antibiotic AM-2282
Alkaloid AM-2282 from Streptomyces
(5R,6S,7S)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one
(5S,6R,7R,9R)-6-methoxy-N,5-dimethyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-aminium
(5S,6R,7R,9R)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one
8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-
(5R,6S,7S,9S)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one
CAS62996-74-1
EINECS613-127-7
Chemical FormulaC28H26N4O3
Molecular Weight466.54
inchiInChI=1/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/p+1/t17-,20-,26-,28+/m1/s1
Package10 mM * 1 mL;2 mg;5 mg;10 mg
PriceEmail to quote
DescriptionsStaurosporine

Staurosporine

MedChemExpress (MCE)

HY-15141

62996-74-1

Antibiotic AM-2282

Descriptions

Staurosporine

Staurosporine

MedChemExpress (MCE)

HY-15141

62996-74-1

Antibiotic AM-2282
STS
AM-2282

99.81%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 1 year -20°C 6 months

Room temperature in continental US
may vary elsewhere.

Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively. Staurosporine also inhibits TAOK2 with an IC50 of 3 μM. Staurosporine is an apoptosis inducer.

Staurosporine, widely used as a protein kinase C (PKC) inhibitor with a broad spectrum of activity, is an alkaloid which can be isolated from the culture broth of Streptomyces staurospores. MC3T3E-1 osteoblasts, expose to Staurosporine (100 nM) for 12 h, release an amount of LDH (12.4±3.1%) that is similar to that release by the control cells(10.0±2.4%), indicating the relative absence of lytic death, which occurs in necrosis. In addition, treatment with Staurosporine (100 nM) results in morphological changes, characteristic of apoptosis: a brightblue fluorescent condensed nuclei seen through a fluorescence microscope after Hoechst 33258-staining, and a reduction of cell volume[2].

The inhibitory effect of Staurosporine is statistically significant at around Wk 10 of tumor promotion. Although statistically significant inhibition is not obtained with 10 ng of Staurosporine in later weeks of the experiment, a decreasing tendency in the percentages of tumor bearing mice and in average numbers of tumors per mouse is apparent. Thus, Staurosporine slightly inhibits tumor promotion of Teleocidin, even at the dose at which Staurosporine itself induced tumors[3]. Staurosponne (0.05 and 0.1 mg/kg intraperitoneal) attenuates the impaired perlormance of water maze and passive avoidance tasks, even though the drug administration began 2 weeks after the lesion. Moreover, Staurosporine (0.1 mg/kg) partially reversed the decrease of choline acetyltransferase activity in the fronto-parietal cortex induced by basal forebrain-lesion. These results suggest that Staurosporine attenuates impairment of learning through reversal of damage to cholinergic neurons induced by basal forebrain-lesion[4].

Mice[3] Female CD-I mice are used. Various amounts of Staurosporine in 10 μL of acetone are applied to the ears of 8-wk-old CD-I mice. The extent of irritation is expressed as the minimum dose of the compound causing irritation. Induction of HOC in Mouse Skin Staurosporine in 0.1 mL of acetone is applied to the skin of the backs of CD-I mice, and a crude enzyme extract is obtained from the skin 18 h later. HDC activity is expressed as pmol of CO2 released per mg of protein per l h of incubation. Induction of ODC in Mouse Skin Staurosporine in 0.2 mL of acetone is applied to the skin of the backs of CD-I mice. After 4 h, a crude enzyme extract is prepared from the epidermis, and its ODC activity is measured. Enzyme activity is expressed as nmol of CO2 per mg of protein per 30 min of incubation. Rats[4] Male Kbl Wistar rats(weighing 270 to 310 g) are used. In the group which is given Staurosporine for 2 weeks, the water maze task and Staurosporine administration are started 2 weeks after the BF-lesion, and the passive avoidance task is carried out 4 weeks after the BFlesion. The rat received Staurosporine at doses of 0.01, 0.03, 0.1, and 0.3 mg/kg (i.p., N=10 in each group for 2 weeks) 30 mm prior to the water maze training sessions and the passive avoidance task acquisitiontrial. In the group which is given Staurosporine for 4 weeks, the drug is first given 2 weeks after the BF-lesion. The water maze task is carried out 4 weeks after the BF-lesion. The passive avoidance task is carried out 6 weeks after the BF-lesion. The rat received Staurosporine at 0.05, 0.1, and 0.2 mg/kg (i.p., N=10 in each group) once a day for 2 weeks before training, and for 2 weeks after the water maze training sessions and the passive avoidance task acquisition trial. Staurosporine is suspended in 0.3% of sodium carboxymethyl cellulose. The vehicle is administered to the non-lesioned controls and the lesioned controls on the same schedule as the Staurosporine-treated animals.

PKC 6 nM (IC50) PKA 15 nM (IC50) c-Fgr 2 nM (IC50) Phosphorylase kinase 3 nM (IC50) S6 kinase (70 kDa) 5 nM (IC50) v-Src 6 nM (IC50) cdc2 9 nM (IC50) TPK-IIB/Syk 16 nM (IC50) Ca2+/CaM PK-I1 20 nM (IC50) MLCK 21 nM (IC50) IR 61 nM (IC50) EGF-R 100 nM (IC50) ERK-1 1500 nM (IC50) CSK 2000 nM (IC50) IGF-IR 6150 nM (IC50) CK2 19500 nM (IC50) CK1 163500 nM (IC50)

| | | |

| | | | | |



[1]. Meggio F, et al. Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur J Biochem. 1995 Nov 15
234(1):317-22.
[Content Brief]

[2]. Chae HJ, et al. Molecular mechanism of staurosporine-induced apoptosis in osteoblasts. Pharmacol Res. 2000 Oct
42(4):373-81.
[Content Brief]

[3]. Yoshizawa S, et al. Tumor-promoting activity of staurosporine, a protein kinase inhibitor on mouse skin.Cancer Res. 1990 Aug 15
50(16):4974-8.
[Content Brief]

[4]. Nabeshima T, et al. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats. J Pharmacol Exp Ther. 1991 May
257(2):562-6.
[Content Brief]

[5]. Yujie Ren, et al. The ORF3a Protein of SARS-CoV-2 Induces Apoptosis in Cells. Cell Mol Immunol. 2020 Jun 18
1-3.
[Content Brief]

Supplier Websitehttp://www.medchemexpress.com/Staurosporine.html
Last Update2025-10-14 16:03:33
MedChemExpress (MCE) also provides

Lipopolysaccharides, from E. coli O55:B5

Category: Natural Products
CAS:
Last Update: 2025-10-14 16:03:33

(1R)-α-Pinene

Category: Natural Products
CAS: 7785-70-8
Last Update: 2025-10-14 16:03:33

Glycyl-L-glutamine

Category: Natural Products
CAS: 13115-71-4
Last Update: 2025-10-14 16:03:33

Triose phosphate

Category: Natural Products
CAS: 591-57-1
Last Update: 2025-10-14 16:03:33

Lactyl-CoA

Category: Natural Products
CAS: 1926-57-4
Last Update: 2025-10-14 16:03:33

12(S)-HPETE

Category: Natural Products
CAS: 71774-10-2
Last Update: 2025-10-14 16:03:33

Pyrithiamine

Category: Natural Products
CAS: 534-64-5
Last Update: 2025-10-14 16:03:33

alpha-CEHC

Category: Natural Products
CAS: 4072-32-6
Last Update: 2025-10-14 16:03:33
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002